Gene	Alteration	Diagnosis	Level	Drug
EGFR	EGFR-KDD	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	L861Q	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	Exon 20 insertion	Non-Small Cell Lung Cancer	4	AP32788
EGFR	T790M	Non-Small Cell Lung Cancer	1	Osimertinib
EGFR	Exon 19 deletion/insertion	Non-Small Cell Lung Cancer	1	Erlotinib, Afatinib, Gefitinib
EGFR	G719C	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	L861R	Non-Small Cell Lung Cancer	4	AP32788
EGFR	G719A	Non-Small Cell Lung Cancer	4	AP32788
EGFR	L858R	Non-Small Cell Lung Cancer	1	Erlotinib, Afatinib, Gefitinib
EGFR	L861R	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	A763_Y764insFQEA	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	L833V	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	G719A	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	E709K	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	G719S	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	S768I	Non-Small Cell Lung Cancer	1	Gefitnib, Afatinib, Erlotinib
EGFR	A750P	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	Exon 19 insertion	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	S768I	Non-Small Cell Lung Cancer	4	AP32788
EGFR	T790M	Non-Small Cell Lung Cancer	R1	Afatinib, Erlotinib, Gefitinib
EGFR	Exon 19 deletion	Non-Small Cell Lung Cancer	1	Erlotinib, Afatinib, Gefitinib
EGFR	G719D	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	L747P	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
EGFR	E709_T710delinsD	Non-Small Cell Lung Cancer	1	Afatinib, Erlotinib, Gefitinib
ROS1	Fusions	Non-Small Cell Lung Cancer	1	Crizotinib
ROS1	D2033N	Non-Small Cell Lung Cancer	3A	Cabozantinib
CDK4	Amplification	Well-Differentiated Liposarcoma	2A	Abemaciclib, Palbociclib
CDK4	Amplification	Dedifferentiated Liposarcoma	2A	Abemaciclib, Palbociclib
CDKN2A	Oncogenic Mutations	Esophagogastric Cancer	4	Palbociclib
CDKN2A	Oncogenic Mutations	Breast Cancer	4	Palbociclib + Letrozole
ERBB2	Amplification	Breast Cancer	3A	Neratinib
ERBB2	Amplification	Breast Cancer	1	Lapatinib + Trastuzumab, Pertuzumab + Trastuzumab, Ado-trastuzumab emtansine, Lapatinib, Trastuzumab
ERBB2	Oncogenic Mutations	Breast Cancer	3A	Neratinib
ERBB2	Exon 20 insertions/deletions	Non-Small Cell Lung Cancer	4	AP32788
ERBB2	Amplification	Esophagogastric Cancer	1	Trastuzumab
ERBB2	Exon 20 insertions	Non-Small Cell Lung Cancer	4	AP32788
ERBB2	V659E	Non-Small Cell Lung Cancer	3A	Lapatinib
ERCC2	Oncogenic Mutations	Bladder Cancer	3A	Cisplatin
ABL1	BCR-ABL1 Fusion	Acute Lymphoid Leukemia	1	Dasatinib, Imatinib
ABL1	BCR-ABL1 Fusion	Chronic Myelogenous Leukemia	1	Nilotinib, Imatinib, Dasatnib
PDGFRA	H650Q	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	Y849S	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	C450_K451insMIEWMI	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	D842V	Gastrointestinal Stromal Tumor	R1	Imatinib
PDGFRA	H845_N848delinsP	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	D842_H845del	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	Y555C	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	V536E	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	Fusions	Myeloproliferative Neoplasm	1	Imatinib
PDGFRA	FIP1L1-PDGFRA Fusion	Leukemia	1	Imatinib
PDGFRA	I843del	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	R841K	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	D842_M844del	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	V469A	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	S566_E571delinsR	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	W559_R560del	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	N848K	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	N659R	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	D846Y	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	V658A	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	C456_N468del	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	N659K	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	C456_R481del	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	V544_L555insAVLVLLVIVIISLI	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	D842V	Gastrointestinal Stromal Tumor	2A	Dasatinib
PDGFRA	V561A	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	V561_I562insER	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	Y375_K455del	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	P577S	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	560_561insER	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	V561D	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	D568N	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	D842I	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	G853D	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	Q579R	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	V568A	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	E311_K312del	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	H845Y	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	Fusions	Myelodysplasia	1	Imatinib
PDGFRA	A633T	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	N659S	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	R748G	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	S584L	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRA	Y849C	Gastrointestinal Stromal Tumor	2A	Imatinib
PDGFRB	Fusions	Myeloproliferative Neoplasm	1	Imatinib
PDGFRB	Fusions	Dermatofibrosarcoma Protuberans	1	Imatinib
PDGFRB	Fusions	Myelodysplasia	1	Imatinib
ESR1	Y537S	Breast Cancer	4	GDC-0810
ESR1	D538G	Breast Cancer	4	GDC-0810
ESR1	Oncogenic Mutations	Breast Cancer	3A	AZD9496, Fulvestrant
TSC1	Oncogenic Mutations	CNS Cancer	2A	Everolimus
TSC1	Oncogenic Mutations	Renal Cell Carcinoma	2A	Everolimus
TSC2	Oncogenic Mutations	CNS Cancer	2A	Everolimus
MDM2	Amplification	Liposarcoma	4	SAR405838
MDM2	Amplification	Liposarcoma	3A	DS-3032b, RG7112
EZH2	Oncogenic Mutations	Diffuse Large B-Cell Lymphoma	4	Tazemetostat, GSK126
MET	D1010N	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	981_1028splice	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	X963_splice	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	X1006_splice	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	X1009_splice	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	963_D1010splice	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	X963_splice	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	D1010Y	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	Amplification	Renal Cell Carcinoma	2A	Cabozantinib
MET	X1009_splice	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	X1008_splice	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	963_D1010splice	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	X1007_splice	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	D1010Y	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	Amplification	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	D1010H	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	X1008_splice	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	981_1028splice	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	X1007_splice	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	D1010N	Non-Small Cell Lung Cancer	2A	Crizotinib
MET	X1006_splice	Non-Small Cell Lung Cancer	3A	Cabozatinib, Capmatinib
MET	D1010H	Non-Small Cell Lung Cancer	2A	Crizotinib
PIK3CA	Oncogenic Mutations	Breast Cancer	3A	Alpelisib + Fulvestrant, Serabelisib, Copanlisib, Fulvestrant + Taselisib, GDC0077, Buparlisib + Fulvestrant
PIK3CA	Oncogenic Mutations	Breast Cancer	4	Alpelisib + Everolimus
AKT1	E17K	Breast Cancer	3A	AZD5363
AKT1	E17K	Ovarian Cancer	3A	AZD5363
FGFR1	Amplification	Lung Squamous Cell Carcinoma	3A	AZD4547, Debio1347
FGFR1	BCR-FGFR1 Fusion	Leukemia	4	Ponatinib
FGFR3	Fusions	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	K650T	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	K650R	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	K650E	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	K650Q	Breast Cancer	4	Debio1347
FGFR3	Fusions	Adrenocortical Carcinoma	3A	JNJ-42756493, Debio1347
FGFR3	S249C	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	K650M	Breast Cancer	4	Debio1347
FGFR3	K650N	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	K650M	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	K650R	Breast Cancer	4	Debio1347
FGFR3	K650Q	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	R248C	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	Y373C	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR3	K650N	Breast Cancer	4	Debio1347
FGFR3	S249C	Breast Cancer	4	Debio1347
FGFR3	K650T	Breast Cancer	4	Debio1347
FGFR3	Y373C	Breast Cancer	4	Debio1347
FGFR3	R248C	Breast Cancer	4	Debio1347
FGFR3	Y375C	Breast Cancer	4	Debio1347
FGFR3	Fusions	Glioma	3A	JNJ-42756493, Debio1347
FGFR3	K650E	Breast Cancer	4	Debio1347
FGFR3	Y375C	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR2	Fusions	Endometrial Cancer	3A	JNJ-42756493, Debio1347
FGFR2	Fusions	Bladder Cancer	3A	JNJ-42756493, Debio1347
FGFR2	Fusions	Cholangiocarcinoma	3A	BGJ398, Debio1347
FGFR2	Fusions	Adrenocortical Carcinoma	3A	JNJ-42756493, Debio1347
ALK	Fusions	Soft Tissue Sarcoma	2A	Crizotinib, Ceritinib
ALK	L1196Q	Non-Small Cell Lung Cancer	3A	Brigatinib
ALK	Fusions	Non-Small Cell Lung Cancer	1	Crizotinib, Alectinib, Ceritinib
ALK	L1196M	Non-Small Cell Lung Cancer	3A	Brigatinib
ALK	R1275Q	Embryonal Tumor	4	Crizotinib
FLT3	FLT3 internal tandem duplications	Acute Myeloid Leukemia	3A	Sorafenib
IDH1	R132H	Glioma	3A	AG-120
IDH1	R132Q	Cholangiocarcinoma	3A	AG-120
IDH1	R132C	Acute Myeloid Leukemia	3A	AG-120
IDH1	R132C	Cholangiocarcinoma	3A	AG-120
IDH1	R132C	Glioma	3A	AG-120
IDH1	R132G	Glioma	3A	AG-120
IDH1	R132H	Acute Myeloid Leukemia	3A	AG-120
IDH1	R132Q	Chondrosarcoma	4	AG-120
IDH1	R132G	Acute Myeloid Leukemia	3A	AG-120
IDH1	R132Q	Intrahepatic Cholangiocarcinoma	3A	AG-120
IDH1	R132G	Intrahepatic Cholangiocarcinoma	3A	AG-120
IDH1	R132Q	Glioma	3A	AG-120
IDH1	R132C	Intrahepatic Cholangiocarcinoma	3A	AG-120
IDH1	R132H	Cholangiocarcinoma	3A	AG-120
IDH1	R132G	Cholangiocarcinoma	3A	AG-120
IDH1	R132G	Chondrosarcoma	4	AG-120
IDH1	R132Q	Acute Myeloid Leukemia	3A	AG-120
IDH1	R132H	Intrahepatic Cholangiocarcinoma	3A	AG-120
IDH1	R132H	Chondrosarcoma	4	AG-120
IDH1	R132C	Chondrosarcoma	4	AG-120
IDH2	R172G	All Liquid Tumors	3A	AG-221
IDH2	R172K	All Liquid Tumors	3A	AG-221
IDH2	R172M	All Liquid Tumors	3A	AG-221
IDH2	R172S	All Liquid Tumors	3A	AG-221
IDH2	R140Q	All Liquid Tumors	3A	AG-221
ARAF	S214C	Non-Small Cell Lung Cancer	3A	Sorafenib
ARAF	S214A	Histiocytosis	3A	Sorafenib
MTOR	E2014K	Bladder Cancer	3A	Everolimus
MTOR	F1888L	Renal Clear Cell Carcinoma	4	Temsirolimus, Rapamycin, Everolimus
MTOR	C1483F	Renal Clear Cell Carcinoma	4	Temsirolimus, Rapamycin, Everolimus
MTOR	L2230V	Renal Clear Cell Carcinoma	4	Temsirolimus, Rapamycin, Everolimus
MTOR	T1977K	Renal Clear Cell Carcinoma	4	Temsirolimus, Rapamycin, Everolimus
MTOR	S2215F	Renal Clear Cell Carcinoma	4	Temsirolimus, Rapamycin, Everolimus
ATM	Truncating Mutations	Prostate Cancer	4	Olaparib
ATM	N2875K	Prostate Cancer	4	Olaparib
MAP2K1	Oncogenic Mutations	Histiocytic Disorder	3A	Cobimetinib, Selumetinib, Trametinib
MAP2K1	Oncogenic Mutations	Melanoma	3A	Cobimetinib, Selumetinib, Trametinib
MAP2K1	Oncogenic Mutations	Low-Grade Serous Ovarian Cancer	3A	Cobimetinib, Selumetinib, Trametinib
MAP2K1	Oncogenic Mutations	Non-Small Cell Lung Cancer	3A	Cobimetinib, Selumetinib, Trametinib
PTCH1	Truncating Mutations	Skin Cancer, Non-Melanoma	3A	Sonidegib, Vismodegib
PTCH1	Truncating Mutations	Embryonal Tumor	3A	Sonidegib
PTEN	Oncogenic Mutations	Endometrial Cancer	4	Olaparib
PTEN	Oncogenic Mutations	All Tumors	4	GSK2636771, AZD8186, LY3023414
PTEN	Oncogenic Mutations	Prostate Cancer	4	LY3023414 + Enzalutamide
JAK2	PCM1-JAK2 Fusion	Leukemia	3A	Ruxolitinib
NF1	Oncogenic Mutations	Neurofibroma	4	Binimetinib, PLX3397
NF1	Oncogenic Mutations	Melanoma	4	Trametinib
NF1	Oncogenic Mutations	Glioblastoma	4	Trametinib
BRCA1	Oncogenic Mutations	Ovarian Cancer	2A	Olaparib
BRCA1	Oncogenic Mutations	Ovarian Cancer	1	Rucaparib
BRAF	V600M	Histiocytosis	2A	Vemurafenib
BRAF	L597Q	Melanoma	4	BGB659
BRAF	V600G	Melanoma	1	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib
BRAF	K601E	Melanoma	3A	Trametinib
BRAF	V600R	Colorectal Cancer	3A	Vemurafenib + Panitumumab
BRAF	V600D	Melanoma	1	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib
BRAF	V600E	Melanoma	1	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib
BRAF	V600G	Histiocytosis	2A	Vemurafenib
BRAF	L597V	Melanoma	4	BGB659
BRAF	G466V	Melanoma	4	Trametinib
BRAF	V600M	Melanoma	1	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib
BRAF	V600K	Melanoma	1	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib
BRAF	KIAA1549-BRAF Fusion	Soft Tissue Sarcoma	4	Sorafenib + Temsirolimus
BRAF	D594N	Melanoma	4	Trametinib
BRAF	V600R	Non-Small Cell Lung Cancer	2A	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib
BRAF	G469V	Melanoma	4	Trametinib
BRAF	V600K	Non-Small Cell Lung Cancer	2A	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib
BRAF	V600K	Colorectal Cancer	3A	Vemurafenib + Panitumumab
BRAF	V600D	Colorectal Cancer	3A	Vemurafenib + Panitumumab
BRAF	L597V	Melanoma	3A	Trametinib
BRAF	V600E	Histiocytosis	2A	Vemurafenib
BRAF	D594E	Melanoma	4	Trametinib
BRAF	V600M	Colorectal Cancer	3A	Vemurafenib + Panitumumab
BRAF	V600D	Non-Small Cell Lung Cancer	2A	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib
BRAF	V600E	Non-Small Cell Lung Cancer	2A	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib
BRAF	Fusions	Ovarian Cancer	3A	Selumetinib + Paclitaxel
BRAF	L597S	Melanoma	3A	Trametinib
BRAF	V600G	Non-Small Cell Lung Cancer	2A	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib
BRAF	L597Q	Melanoma	3A	Trametinib
BRAF	L597R	Melanoma	3A	Trametinib
BRAF	G469A	Melanoma	4	Trametinib
BRAF	V600M	Non-Small Cell Lung Cancer	2A	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib
BRAF	V600G	Colorectal Cancer	3A	Vemurafenib + Panitumumab
BRAF	G596C	Melanoma	4	Trametinib
BRAF	V600E	Colorectal Cancer	3A	Vemurafenib + Panitumumab
BRAF	V600D	Histiocytosis	2A	Vemurafenib
BRAF	V600R	Melanoma	1	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib
BRAF	V600R	Histiocytosis	2A	Vemurafenib
BRAF	V600K	Histiocytosis	2A	Vemurafenib
BRCA2	Oncogenic Mutations	Ovarian Cancer	2A	Olaparib
BRCA2	Oncogenic Mutations	Ovarian Cancer	1	Rucaparib
KIT	V555_L576del	Gastrointestinal Stromal Tumor	2A	Nilotinib
KIT	I653T	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	W557_K558del	Gastrointestinal Stromal Tumor	2A	Nilotinib, Dasatinib, Sorafenib
KIT	V654A	Thymic Tumor	2A	Sunitinib
KIT	D816F	Gastrointestinal Stromal Tumor	2A	Dasatinib
KIT	D820G	Gastrointestinal Stromal Tumor	1	Regorafenib, Sunitinib
KIT	D820Y	Gastrointestinal Stromal Tumor	1	Regorafenib
KIT	K642E	Gastrointestinal Stromal Tumor	2A	Nilotinib, Sorafenib
KIT	K558N	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	Exon 11 mutations	Gastrointestinal Stromal Tumor	1	Regorafenib, Sunitinib, Imatinib
KIT	V654A	Gastrointestinal Stromal Tumor	2A	Nilotinib
KIT	L576P	Melanoma	2A	Imatinib
KIT	A502_Y503dup	Thymic Tumor	2A	Sunitinib
KIT	V559D	Gastrointestinal Stromal Tumor	2A	Nilotinib, Dasatinib
KIT	T417_D419delinsI	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	V559C	Gastrointestinal Stromal Tumor	2A	Nilotinib
KIT	V654A	Gastrointestinal Stromal Tumor	1	Sunitinib
KIT	V530I	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	T417_D419delinsRG	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	V569_L576del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	E554_K558del	Gastrointestinal Stromal Tumor	1	Sunitinib, Imatinib
KIT	L576P	Thymic Tumor	2A	Sunitinib
KIT	V559del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	Q556_K558del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	V560del	Gastrointestinal Stromal Tumor	1	Sunitinib, Imatinib
KIT	M541L	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	K550_W557del	Gastrointestinal Stromal Tumor	1	Regorafenib, Sunitinib, Imatinib
KIT	N505I	Thymic Tumor	2A	Sorafenib
KIT	N822H	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	V560D	Thymic Tumor	2A	Sunitinib
KIT	P577_W582delinsPYD	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	K558delinsNP	Gastrointestinal Stromal Tumor	1	Regorafenib, Sunitinib, Imatinib
KIT	Exon 11 mutations	Thymic Tumor	2A	Sunitinib
KIT	V555_V559del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	D820G	Thymic Tumor	2A	Sunitinib, Sorafenib
KIT	V559_V560del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	N505I	Gastrointestinal Stromal Tumor	2A	Sorafenib
KIT	D419del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	N564_Y578del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	K558delinsNP	Thymic Tumor	2A	Sunitinib
KIT	Y570H	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	P573_D579del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	K550_W557del	Thymic Tumor	2A	Sunitinib
KIT	K642E	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	V559A	Melanoma	2A	Imatinib
KIT	V559C	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	V555_L576del	Thymic Tumor	2A	Sunitinib
KIT	W557R	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	P577_D579del	Gastrointestinal Stromal Tumor	2A	Sorafenib
KIT	D820E	Thymic Tumor	2A	Sorafenib
KIT	W557G	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	D820E	Gastrointestinal Stromal Tumor	2A	Sorafenib
KIT	K558_V559del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	E554_V559del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	M552_W557del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	H697Y	Gastrointestinal Stromal Tumor	1	Sunitinib
KIT	P551_M552del	Thymic Tumor	2A	Sunitinib
KIT	P551_M552del	Gastrointestinal Stromal Tumor	1	Sunitinib
KIT	F522C	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	D820A	Thymic Tumor	2A	Sorafenib
KIT	P577_D579del	Thymic Tumor	2A	Sorafenib
KIT	D820A	Gastrointestinal Stromal Tumor	2A	Nilotinib, Sorafenib
KIT	N822K	Gastrointestinal Stromal Tumor	1	Regorafenib
KIT	V559G	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	D816Y	Gastrointestinal Stromal Tumor	2A	Dasatinib
KIT	Y553_K558del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	K642E	Melanoma	2A	Imatinib
KIT	V560G	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	L576P	Gastrointestinal Stromal Tumor	1	Sunitinib, Imatinib
KIT	Y578C	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	V559D	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	N822I	Gastrointestinal Stromal Tumor	2A	Dasatinib
KIT	T574insTQLPYD	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	L576P	Gastrointestinal Stromal Tumor	2A	Nilotinib, Dasatinib
KIT	D820Y	Gastrointestinal Stromal Tumor	2A	Nilotinib, Dasatinib, Sorafenib
KIT	V560G	Gastrointestinal Stromal Tumor	2A	Dasatinib
KIT	V560del	Thymic Tumor	2A	Sunitinib
KIT	E554_I571del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	W557_K558del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	D820G	Gastrointestinal Stromal Tumor	2A	Nilotinib, Dasatinib, Sorafenib
KIT	E554_K558del	Thymic Tumor	2A	Sunitinib
KIT	W557_K558del	Thymic Tumor	2A	Sorafenib
KIT	A502_Y503dup	Gastrointestinal Stromal Tumor	1	Sunitinib
KIT	H697Y	Thymic Tumor	2A	Sunitinib
KIT	I563_L576del	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	V560D	Gastrointestinal Stromal Tumor	1	Regorafenib, Sunitinib, Imatinib
KIT	Exon 9 mutations	Gastrointestinal Stromal Tumor	1	Regorafenib, Sunitinib, Imatinib
KIT	Exon 9 mutations	Thymic Tumor	2A	Sunitinib
KIT	D579del	Thymic Tumor	2A	Sunitinib
KIT	V555_L576del	Gastrointestinal Stromal Tumor	1	Sunitinib, Imatinib
KIT	D820Y	Thymic Tumor	2A	Sorafenib
KIT	D816V	Gastrointestinal Stromal Tumor	2A	Nilotinib
KIT	K642E	Thymic Tumor	2A	Sorafenib
KIT	Y553N	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	D579del	Gastrointestinal Stromal Tumor	1	Sunitinib, Imatinib
KIT	P838L	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	N822Y	Gastrointestinal Stromal Tumor	1	Imatinib
KIT	K558_E562del	Gastrointestinal Stromal Tumor	1	Imatinib
KRAS	Oncogenic Mutations	Colorectal Cancer	3A	Cobimetinib + Atezolizumab
KRAS	Oncogenic Mutations	Colorectal Cancer	R1	Panitumumab, Cetuximab
KRAS	Wildtype	Colorectal Cancer	1	Regorafenib, Panitumumab, Cetuximab
RAF1	S257L	Lung Adenocarcinoma	4	Sorafenib
NRAS	Oncogenic Mutations	Thyroid Cancer	3A	Selumetinib + Radioiodine Uptake Therapy
NRAS	Oncogenic Mutations	Colorectal Cancer	R1	Panitumumab, Cetuximab
NRAS	Oncogenic Mutations	Melanoma	3A	Binimetinib, Binimetinib + Ribociclib
NRAS	Oncogenic Mutations	Colorectal Cancer	3A	Cobimetinib + Atezolizumab
NTRK1	Fusions	All Tumors	3A	LOXO-101
NTRK1	Fusions	Salivary Gland Cancer	3A	Entrectinib
NTRK2	Fusions	Salivary Gland Cancer	3A	LOXO-101, Entrectinib
NTRK3	Fusions	Salivary Gland Cancer	3A	LOXO-101, Entrectinib
RET	Fusions	Non-Small Cell Lung Cancer	2A	Cabozantinib
RET	Fusions	Non-Small Cell Lung Cancer	3A	Vandetanib
